Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

897 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Small-particle Inhaled Corticosteroid as First-line or Step-up Controller Therapy in Childhood Asthma.
van Aalderen WM, Grigg J, Guilbert TW, Roche N, Israel E, Martin RJ, Colice G, Postma DS, Hillyer EV, Burden A, Thomas V, von Ziegenweidt J, Price D. van Aalderen WM, et al. Among authors: postma ds. J Allergy Clin Immunol Pract. 2015 Sep-Oct;3(5):721-31.e16. doi: 10.1016/j.jaip.2015.04.012. Epub 2015 May 29. J Allergy Clin Immunol Pract. 2015. PMID: 26032474 Free article.
Cost-effectiveness of initiating extrafine- or standard size-particle inhaled corticosteroid for asthma in two health-care systems: a retrospective matched cohort study.
Martin RJ, Price D, Roche N, Israel E, van Aalderen WM, Grigg J, Postma DS, Guilbert TW, Hillyer EV, Burden A, von Ziegenweidt J, Colice G. Martin RJ, et al. Among authors: postma ds. NPJ Prim Care Respir Med. 2014 Oct 9;24:14081. doi: 10.1038/npjpcrm.2014.81. NPJ Prim Care Respir Med. 2014. PMID: 25297072 Free PMC article.
Reply.
van Aalderen WM, Grigg J, Guilbert TW, Roche N, Colice G, Postma DS, Hillyer EV, Price DB. van Aalderen WM, et al. Among authors: postma ds. J Allergy Clin Immunol Pract. 2016 Mar-Apr;4(2):372-3. doi: 10.1016/j.jaip.2015.12.006. J Allergy Clin Immunol Pract. 2016. PMID: 26968965 No abstract available.
Effectiveness of initiating extrafine-particle versus fine-particle inhaled corticosteroids as asthma therapy in the Netherlands.
van der Molen T, Postma DS, Martin RJ, Herings RM, Overbeek JA, Thomas V, Miglio C, Dekhuijzen R, Roche N, Guilbert T, Israel E, van Aalderen W, Hillyer EV, van Rysewyk S, Price DB. van der Molen T, et al. Among authors: postma ds. BMC Pulm Med. 2016 May 17;16(1):80. doi: 10.1186/s12890-016-0234-0. BMC Pulm Med. 2016. PMID: 27184175 Free PMC article.
Identifying Risk of Future Asthma Attacks Using UK Medical Record Data: A Respiratory Effectiveness Group Initiative.
Blakey JD, Price DB, Pizzichini E, Popov TA, Dimitrov BD, Postma DS, Josephs LK, Kaplan A, Papi A, Kerkhof M, Hillyer EV, Chisholm A, Thomas M. Blakey JD, et al. Among authors: postma ds. J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1015-1024.e8. doi: 10.1016/j.jaip.2016.11.007. Epub 2016 Dec 22. J Allergy Clin Immunol Pract. 2017. PMID: 28017629
Asthma-Related Outcomes in Patients Initiating Extrafine Ciclesonide or Fine-Particle Inhaled Corticosteroids.
Postma DS, Dekhuijzen R, van der Molen T, Martin RJ, van Aalderen W, Roche N, Guilbert TW, Israel E, van Eickels D, Khalid JM, Herings RM, Overbeek JA, Miglio C, Thomas V, Hutton C, Hillyer EV, Price DB. Postma DS, et al. Allergy Asthma Immunol Res. 2017 Mar;9(2):116-125. doi: 10.4168/aair.2017.9.2.116. Allergy Asthma Immunol Res. 2017. PMID: 28102056 Free PMC article.
897 results